Descriptor English: | Fluocinolone Acetonide | ||||||
Descriptor Spanish: |
Fluocinolona Acetonida
| ||||||
Descriptor Portuguese: | Fluocinolona Acetonida | ||||||
Descriptor French: | Fluocinolone acétonide | ||||||
Entry term(s): |
Acetonide, Fluocinolone Acetonide, Fluortriamcinolone Alvadermo Capex Co Fluocin Co-Fluocin Cortiespec Derma Smooth FS Derma-Smooth FS Flucinar Fluocid Fluodermo Fluonid Fluortriamcinolone Acetonide Fluotrex Flurosyn Flusolgen Gelidina Jellin Jellisoft Synalar Synalar HP Synalar-HP Synamol Synemol |
||||||
Tree number(s): |
D04.210.500.745.432.370 D04.210.500.908.394 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D005446 | ||||||
Scope note: | A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Inflammatory Agents Glucocorticoids |
||||||
Registry Number: | 0CD5FD6S2M | ||||||
CAS Type 1 Name: | Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)- | ||||||
Public MeSH Note: | 65 |
||||||
History Note: | 65(63) |
||||||
DeCS ID: | 22460 | ||||||
Unique ID: | D005446 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1965/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Fluocinolone Acetonide
- Preferred
Flurosyn
- Narrower
Jellin
- Narrower
Synalar
- Narrower
Synemol
- Narrower
Alvadermo
- Narrower
Capex
- Narrower
Co-Fluocin
- Narrower
Cortiespec
- Narrower
Derma-Smooth FS
- Narrower
Flucinar
- Narrower
Fluocid
- Narrower
Fluodermo
- Narrower
Fluonid
- Narrower
Fluotrex
- Narrower
Flusolgen
- Narrower
Gelidina
- Narrower
Concept UI |
M0008592 |
Scope note | A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) |
Preferred term | Fluocinolone Acetonide |
Entry term(s) |
Acetonide, Fluocinolone Acetonide, Fluortriamcinolone Fluortriamcinolone Acetonide |
Concept UI |
M0478604 |
Preferred term | Flurosyn |
Concept UI |
M0478608 |
Preferred term | Jellin |
Entry term(s) |
Jellisoft |
Concept UI |
M0372968 |
Preferred term | Synalar |
Entry term(s) |
Synalar HP Synalar-HP |
Concept UI |
M0372967 |
Preferred term | Synemol |
Entry term(s) |
Synamol |
Concept UI |
M0478593 |
Preferred term | Alvadermo |
Concept UI |
M0478594 |
Preferred term | Capex |
Concept UI |
M0478595 |
Preferred term | Co-Fluocin |
Entry term(s) |
Co Fluocin |
Concept UI |
M0478596 |
Preferred term | Cortiespec |
Concept UI |
M0478597 |
Preferred term | Derma-Smooth FS |
Entry term(s) |
Derma Smooth FS |
Concept UI |
M0372969 |
Preferred term | Flucinar |
Concept UI |
M0478598 |
Preferred term | Fluocid |
Concept UI |
M0478599 |
Preferred term | Fluodermo |
Concept UI |
M0456345 |
Preferred term | Fluonid |
Concept UI |
M0478600 |
Preferred term | Fluotrex |
Concept UI |
M0478605 |
Preferred term | Flusolgen |
Concept UI |
M0478607 |
Preferred term | Gelidina |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey